Video: Inscripta Customers Describe Their Experience with the Onyx Platform
By now you may have heard about our automated benchtop Onyx™ genome engineering platform — but have you seen it...
Inscripta Expands Operations with New Office and Association Membership in Europe
Exciting news: Inscripta is heading to Europe! We are expanding operations beyond our U.S. base with a new office in...
Scientists Deploy the MAD7™ Nuclease for Mammalian Genome Edits
Even before we launched our benchtop Onyx™ platform for automated genome engineering, the Inscripta team had already made progress in...
Inside Inscripta: Patrick Westfall, Microbe
As we continue profiling members of the Inscripta team, we’re delighted to chat with Patrick Westfall, Senior Director, Microbe. The...
How Inscripta Technology Accelerates Adaptive Laboratory Evolution Experiments
While adaptive laboratory evolution (ALE) is a powerful approach for developing microbial strains that thrive in challenging growth environments, the...
Inside Inscripta: Nandini Krishnamurthy, Applications
When we developed the Onyx™ Digital Genome Engineering platform, we decided to offer it first to customers for microbial applications...
University of Edinburgh Scientists Demonstrate Value of Open-Source MAD7™ Enzyme
Here at Inscripta, our vision for expanding access to digital genome engineering has always been broader than developing an automated...
McKinsey Report: Bioeconomy to Drive $4 Trillion Globally
We are not the only ones excited about the potential for a bio-driven economy. A report from analysts at the...
We Won! Onyx™ Platform Named to The Scientist’s Top 10 Innovations for 2020
For developers of a brand new technology platform, it doesn’t get much better than this: we are delighted to report...